Vaccines
The global travel vaccines market experienced significant growth in 2021, reaching a value of $3.2 billion. According to a new report by ResearchAndMarkets.com, the market is expected to witness a compound annual growth rate (CAGR) of 11.1% during the forecast period 2022-2027, driven by increasing international travel,
Vaccines
Global advocacy organization Oxfam has secured two victories in its push to get pharmaceutical companies Johnson & Johnson and Moderna to reveal their COVID-19 vaccine pricing strategies and share vaccine technology. Ahead of their annual shareholder meetings, both companies will allow their investors to vote on Oxfam-backed proposals. The measures
Pharmaceutical industry
The World Health Organization (WHO) has announced the creation of a global training center in South Korea to help poorer countries develop mRNA vaccines, antibodies, and cancer treatments using the technology that has successfully been used to make COVID-19 vaccines. The hub, which will share mRNA technology being developed by
Pharmaceutical industry
Investment firm AXS Investments, LLC has filed with the SEC to introduce a series of double-leveraged exchange-traded funds (ETFs) that track the performance of individual U.S.-listed equity securities. Each fund aims to provide daily returns twice that of the underlying security, offering a unique investment opportunity for traders
Vaccines
A new prospective cohort study in England, known as VIVALDI, has shed light on the effectiveness of double-dose vaccination in older Long-Term Care Facility (LTCF) residents, particularly in relation to their immune responses to SARS-CoV-2. The study, which has not been peer-reviewed, involved 402 residents with a median age of
Pharmaceutical industry
The Atopic Dermatitis market is expected to witness significant growth in the coming years, driven by the emergence of new and innovative therapies, increased awareness, and improved access to healthcare services. A recent report by DelveInsight Business Research, LLP highlights the potential launch of several new therapies, including Abrocitinib/PF-04965842,
Vaccines
Thailand's top paediatricians are reevaluating the COVID-19 vaccine protocol for children, with Somsak Lolekha from the Paediatric Society of Thailand advocating for a simplified approach to vaccination. According to Somsak, two doses of an mRNA vaccine, such as Pfizer, are sufficient to protect children from severe illness. This
Pharmaceutical industry
The global Alzheimer drugs market is expected to grow significantly, driven by the rising prevalence of Alzheimer's disease and advancements in telehealth services. The market was valued at USD 6537.0 Million in 2021 and is anticipated to reach USD 6537.0 Million by the end of 2027,
COVID-19
Xanadu Bio, a privately held company specializing in next-generation delivery of mRNA and other nucleic acids, has announced a comprehensive exclusive license agreement with Yale University for the PACE technology. This collaboration will enable the development of innovative intranasal mRNA vaccine boosters targeting aerosolized viruses, including SARS-CoV-2. By leveraging the
COVID-19
The global Alzheimer's drugs market is driven by the increasing prevalence of Alzheimer's disease, growth in the geriatric population, and rising demand for effective therapies. The market was valued at USD 6537.0 Million in 2021 and is expected to grow due to the expansion of
Pharmaceutical industry
The stock market rally persisted on Monday, despite Monday's Nasdaq and S&P 500 losses, with Alphabet, Blackstone, CF Industries, and Cheniere Energy being highlighted as top stocks to buy and watch. These companies are in or near new buy zones, according to Investors Business Daily (IBD)
COVID-19
The pediatric clinic at Makarios hospital has treated 250 children with Covid-19, including about a third who were infants, since the pandemic began. Head of the clinic, Avraam Elia, warned that infants are at risk of dying from the virus or developing the life-threatening MIS-C syndrome, and emphasized the importance
